$RZLT
Rezolute, Inc. Stock $rzlt

$rzlt Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000114420417005491 Filed on February 02, 2017

Income Statement

Concept	2016 Q4	2015 Q4
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.730M	$1.490M
YoY Change	16.11%	7.19%
% of Gross Profit
Research & Development	$3.075M	$2.524M
YoY Change	21.85%	61.15%
% of Gross Profit
Depreciation & Amortization	$278.1K	$150.2K
YoY Change	85.11%	392.33%
% of Gross Profit
Operating Expenses	$4.889M	$4.067M
YoY Change	20.23%	32.5%
Operating Profit	-$4.889M	-$4.067M
YoY Change	20.23%	32.5%
Interest Expense	$0.00	$1.379K
YoY Change	-100.0%	-40.02%
% of Operating Profit
Other Income/Expense, Net	$1.313K	$543.00
YoY Change	141.8%	-99.59%
Pretax Income	-$4.890M	-$4.070M
YoY Change	20.15%	38.44%
Income Tax
% Of Pretax Income
Net Earnings	-$4.888M	-$4.066M
YoY Change	20.21%	38.51%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$5.963M	-$8.306M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q4	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.570M	$1.710M
YoY Change	108.77%	-80.09%
Cash & Equivalents	$3.570M	$1.710M
Short-Term Investments
Other Short-Term Assets	$213.4K	$130.0K
YoY Change	64.19%	94.64%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.787M	$1.840M
YoY Change	105.79%	-78.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.729M	$6.070M
YoY Change	-5.62%	415.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$380.0K	$560.0K
YoY Change	-32.14%	-25.33%
Total Long-Term Assets	$6.152M	$6.690M
YoY Change	-8.04%	236.67%
TOTAL ASSETS
Total Short-Term Assets	$3.787M	$1.840M
Total Long-Term Assets	$6.152M	$6.690M
Total Assets	$9.938M	$8.530M
YoY Change	16.51%	-20.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.530M	$2.220M
YoY Change	-31.08%	109.43%
Accrued Expenses	$0.00	$10.00K
YoY Change	-100.0%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$10.00K	$60.00K
YoY Change	-83.33%	0.0%
Long-Term Debt Due	$0.00	$70.00K
YoY Change	-100.0%	-22.22%
Total Short-Term Liabilities	$1.670M	$2.490M
YoY Change	-32.93%	5.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$340.0K	$460.0K
YoY Change	-26.09%	-0.87%
Total Long-Term Liabilities	$340.0K	$460.0K
YoY Change	-26.09%	-13.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.670M	$2.490M
Total Long-Term Liabilities	$340.0K	$460.0K
Total Liabilities	$2.010M	$2.953M
YoY Change	-31.93%	1.61%
SHAREHOLDERS EQUITY
Retained Earnings	-$52.75M	-$36.46M
YoY Change	44.66%	59.25%
Common Stock	$40.95K	$24.34K
YoY Change	68.25%	10.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.933M	$3.778M
YoY Change
Total Liabilities & Shareholders Equity	$9.938M	$8.535M
YoY Change	16.45%	-20.41%

Cashflow Statement

Concept	2016 Q4	2015 Q4
OPERATING ACTIVITIES
Net Income	-$4.888M	-$4.066M
YoY Change	20.21%	38.51%
Depreciation, Depletion And Amortization	$278.1K	$150.2K
YoY Change	85.11%	392.33%
Cash From Operating Activities	-$3.090M	-$2.290M
YoY Change	34.93%	31.61%
INVESTING ACTIVITIES
Capital Expenditures	-$140.0K	-$680.0K
YoY Change	-79.41%	353.33%
Acquisitions
YoY Change
Other Investing Activities	$120.0K	$450.0K
YoY Change	-73.33%
Cash From Investing Activities	-$30.00K	-$230.0K
YoY Change	-86.96%	53.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.330M	1.870M
YoY Change	78.07%	-69.74%
NET CHANGE
Cash From Operating Activities	-3.090M	-2.290M
Cash From Investing Activities	-30.00K	-230.0K
Cash From Financing Activities	3.330M	1.870M
Net Change In Cash	210.0K	-650.0K
YoY Change	-132.31%	-115.15%
FREE CASH FLOW
Cash From Operating Activities	-$3.090M	-$2.290M
Capital Expenditures	-$140.0K	-$680.0K
Free Cash Flow	-$2.950M	-$1.610M
YoY Change	83.23%	1.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	10000	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1530763	USD
CY2016Q4	us-gaap	Assets Assets	9938401	USD
CY2016Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	375000	USD
CY2016Q2	us-gaap	Interest Payable Current InterestPayableCurrent	15079	USD
CY2016Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	11955	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1730500	USD
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	400038	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5728844	USD
CY2016Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40788241	shares
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2125966	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7353847	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3646	USD
	us-gaap	Depreciation Depreciation	546429	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2125966	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6058955	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	-488865	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-2800	USD
	antb	Increase Decrease In Deferred Lease Liability IncreaseDecreaseInDeferredLeaseLiability	-58924	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	5655177	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-619875	USD
	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	23128	USD
	antb	Warrant Expense WarrantExpense	0	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-29153	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015Q4	us-gaap	Cash Cash	1708489	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	272587	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-85087	USD
	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	-187500	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	12097	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2000115	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	105715	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	400038	USD
CY2016Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	23128	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	3786589	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	213441	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	40954	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	35114	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	60640517	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52782569	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-52748627	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44044830	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	7932844	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	8772853	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9938401	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10903391	USD
CY2016Q2	us-gaap	Cash Cash	4062013	USD
CY2016Q4	us-gaap	Cash Cash	3573148	USD
CY2016Q2	us-gaap	Liabilities Liabilities	2130538	USD
CY2016Q4	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	301520	USD
CY2015Q4	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	1142198	USD
CY2016Q4	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	1909518	USD
CY2015Q4	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	340289	USD
CY2016Q4	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	194783	USD
CY2015Q4	us-gaap	Manufacturing Costs ManufacturingCosts	755464	USD
CY2016Q4	us-gaap	Manufacturing Costs ManufacturingCosts	567430	USD
CY2015Q4	antb	Investor Relations InvestorRelations	57402	USD
CY2016Q4	antb	Investor Relations InvestorRelations	87428	USD
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1313	USD
CY2015Q4	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	1170679	USD
CY2016Q4	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	1285052	USD
CY2015Q4	us-gaap	Professional Fees ProfessionalFees	116112	USD
CY2016Q4	us-gaap	Professional Fees ProfessionalFees	139865	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	4066536	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	4889244	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4066536	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4889244	USD
CY2015Q4	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	198466	USD
CY2015Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	193	USD
CY2016Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2015Q4	us-gaap	Interest Expense InterestExpense	1379	USD
CY2016Q4	us-gaap	Interest Expense InterestExpense	0	USD
CY2015Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1729	USD
CY2016Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1313	USD
CY2015Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	543	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-4065993	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-4887931	USD
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
CY2015Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24338219	shares
CY2016	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5523706	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3106437	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3761837	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-14935542	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	9053807	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1778962	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	5974385	USD
CY2016	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5307909	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2929084	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3899343	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3646	USD
	us-gaap	Depreciation Depreciation	220537	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1965993	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4798289	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	-3570217	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1000	USD
	antb	Increase Decrease In Deferred Lease Liability IncreaseDecreaseInDeferredLeaseLiability	-4098	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1847947	USD
	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	46453	USD
	antb	Warrant Expense WarrantExpense	21092	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-65739	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-450167	USD
CY2015Q2	us-gaap	Cash Cash	5278706	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	1257542	USD
	us-gaap	Payments For Proceeds From Other Deposits PaymentsForProceedsFromOtherDeposits	-187500	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	295965	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6361499	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	683194	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	18016	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1425678	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	879250	USD
CY2016Q2	us-gaap	Preferred Stock Redemption Price Per Share PreferredStockRedemptionPricePerShare	1.95
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	512820	shares
CY2016Q2	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1000000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	392855	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	511563	USD
CY2016Q4	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	1230	USD
CY2016	antb	Fair Value Of Warrants FairValueOfWarrants	11955	USD
	antb	Fair Value Of Warrants FairValueOfWarrants	1230	USD
CY2014Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	28939	USD
CY2014Q2	antb	Payments Of Monthly Lease Adjusted Annually Percentage PaymentsOfMonthlyLeaseAdjustedAnnuallyPercentage	0.03	pure
	antb	Fair Value Of Financial Instruments Earnings FairValueOfFinancialInstrumentsEarnings	10725	USD
CY2016Q4	antb	Working Capital Deficit WorkingCapitalDeficit	2116620	USD
CY2016Q4	us-gaap	Depreciation Depreciation	278074	USD
CY2015Q4	us-gaap	Depreciation Depreciation	150225	USD
	antb	Investor Relations Expense InvestorRelationsExpense	67275	USD
CY2014Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4275172	USD
CY2016Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	14133769	USD
CY2014Q2	antb	Adjusted Triple Net Expense Of Lease Payments AdjustedTripleNetExpenseOfLeasePayments	34381	USD
CY2014Q2	us-gaap	Area Of Land AreaOfLand	27000	sqft
CY2014Q2	us-gaap	Security Deposit SecurityDeposit	750000	USD
	us-gaap	Proceeds From Other Deposits ProceedsFromOtherDeposits	375000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	335747	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	186047	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	381360	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40952450	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40952450	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35110916	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35110916	shares
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	558115	USD
	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	2007401	USD
	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	3213358	USD
	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	604280	USD
	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	466258	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	1375511	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	1079137	USD
	antb	Investor Relations InvestorRelations	114320	USD
	antb	Investor Relations InvestorRelations	155535	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9130	USD
	us-gaap	Professional Fees ProfessionalFees	238173	USD
	us-gaap	Operating Expenses OperatingExpenses	7366135	USD
	us-gaap	Operating Expenses OperatingExpenses	8712927	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7366135	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8712927	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	403649	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3075379	USD
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2523877	USD
CY2016Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1813865	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	964	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
	us-gaap	Interest Expense InterestExpense	2992	USD
	us-gaap	Interest Expense InterestExpense	1595	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	14316	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	10725	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12288	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8703797	USD
	antb	Facilities And Other Costs FacilitiesAndOtherCosts	802555	USD
	antb	Facilities And Other Costs FacilitiesAndOtherCosts	504951	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5561308	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4492143	USD
CY2015Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1542659	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3151619	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2873992	USD
	antb	Stock Issued During Period Value Conversion Of Note Payable StockIssuedDuringPeriodValueConversionOfNotePayable	59517	USD
	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	516550	USD
	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	90852	USD
	antb	Conversionofconvertiblenotespayabletocommonstock Conversionofconvertiblenotespayabletocommonstock	50000	USD
	antb	Conversionofconvertiblenotespayabletocommonstock Conversionofconvertiblenotespayabletocommonstock	0	USD
	antb	Conversionofinterestpayabletocommonstock Conversionofinterestpayabletocommonstock	9517	USD
	antb	Conversionofinterestpayabletocommonstock Conversionofinterestpayabletocommonstock	0	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b><u>Note 1 Nature of Operations</u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b> </b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">These financial statements represent the consolidated financial statements of AntriaBio, Inc. (“AntriaBio”), and its wholly owned operating subsidiary, AntriaBio Delaware, Inc. (“Antria Delaware”). AntriaBio and Antria Delaware are collectively referred to herein as the “Company”. </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Use of Estimates</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong> </strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: estimated useful lives and impairment of depreciable assets, the fair value of share-based payments and warrants, fair value of derivative instruments, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	11955	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7154522	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6863920	USD
CY2016Q4	antb	Investor Relations Expense InvestorRelationsExpense	31050	USD
CY2016Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	50000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1296009	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P7Y
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2015Q4	us-gaap	Preferred Stock Conversion Basis PreferredStockConversionBasis	The Series A Stock had a conversion feature at the option of the holder that could be converted at any time at a conversion rate of $1.95, subject to adjustment, into common stock. The shares also had a mandatory conversion feature at the same conversion rate if one of the following events occurs: 1) Upon vote or consent of 2/3 of the then outstanding Series A Stock; 2) Upon the Companys listing to NASDAQ Stockmarket or the NYSE MKT and the Companys common stock trades for 30 days for at least 155% of the Series A Stock conversion price; or 3) the Company closes an underwritten public offering of at least $15 million in gross proceeds with an offering price of at least 155% of the Series A Stock conversion price. The Series A Stocks conversion price was subject to weighted average anti-dilution protection, as defined, and was subject to adjustments for stock splits, dividends, and similar events

Files In Submission

Name	View Source	Status
0001144204-17-005491-index-headers.html	Edgar Link	pending
0001144204-17-005491-index.html	Edgar Link	pending
0001144204-17-005491.txt	Edgar Link	pending
0001144204-17-005491-xbrl.zip	Edgar Link	pending
antb-20161231.xml	Edgar Link	completed
antb-20161231.xsd	Edgar Link	pending
antb-20161231_cal.xml	Edgar Link	unprocessable
antb-20161231_def.xml	Edgar Link	unprocessable
antb-20161231_lab.xml	Edgar Link	unprocessable
antb-20161231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v457646_10q.htm	Edgar Link	pending
v457646_ex31-1.htm	Edgar Link	pending
v457646_ex31-2.htm	Edgar Link	pending
v457646_ex32-1.htm	Edgar Link	pending
v457646_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RZLT
Rezolute, Inc. Stock $rzlt

2016 Q4 Form 10-Q Financial Statement

#000114420417005491 Filed on February 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT Rezolute, Inc. Stock $rzlt

2016 Q4 Form 10-Q Financial Statement

#000114420417005491 Filed on February 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT
Rezolute, Inc. Stock $rzlt